Drugs / RinGlar®
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04101383 | Oct 2017 → Feb 2018 | — | Geropharm | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RinGlar | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04101383 ↗ |
| Route | Subcutaneous | “Single subcutaneous administration of RinGlar® in dose 0.6 Units/kg” NCT04101383 ↗ |